• 한국자원식물학회:학술대회논문집
• /
• 한국자원식물학회 2019년도 추계학술대회
• /
• pp.4-4
• /
• 2019

과학기술의 발달로 인해 국민의 생활수준 향상과 건강에 대한 관심 증대 등으로 인해 화장품을 비롯한 향장품산업, 기능성식품 및 천연물 신약 등에 대한 자원식물 유래 천연물질 수요가 증가되고 있다. 자원식물을 활용한 기능성 제품의 개발은 국민의 건강증진 뿐만 아니라 국제경쟁력 강화나 윤택한 삶의 추구에도 절대적 역할을 할 것으로 기대되고 있으며, 이러한 수요에 따라 제주의 특산 또는 우수 자원식물을 활용한 생리활성 물질에 대한 연구들이 활발하게 진행되고 있다. 우리나라에 자생하는 관속식물은 총 4,500여 종으로 국가생물종목록에 작성되어 있으며 제주의 생물자원 중 관속식물은 해발 1,950m 한라산의 영향으로 2,200여 종이 분포한다고 최근 기록되고 있다. 이 중 식용 및 약용으로 활용 가능성을 갖고 있는 식물자원들도 약 800여 종이 분포한다고 보고되고 있다. 이들 자원은 대한약전, 생약규격집, 중약본초, 중약대사전 등 문헌에 근거한 자원으로 공정서에 수록된 약용식물 약 500여 종 중 제주 분포 약용식물도 217종으로 조사되고 있다. 이러한 제주의 약용식물 자원은 다양한 한의약재로 활용되고 있으며 민간약으로 활용되는 약용식물도 170여 종이 포함되어 있다. 특히, 최근에는 나고야의정서 발효에 따른 자원전쟁이 시작되어 자원식물을 포함한 생물자원 관리의 중요성이 그 어느 때보다 부각되고 있어 각 지역마다 자생 생물자원에 대한 주권을 확보하기 위한 연구들이 많이 추진되고 있다. 이와 더불어 지자체연구소인 생물종다양성연구소에서도 제주에 분포하는 자원식물들에 대한 주권 확립을 위한 생태사진 900여 종, 표본 1,400여 종, 유전자 정보 800여 종 등을 확보하고 있으며 추출물 2,000점을 확보하여 산업소재화 연구를 추진하고 있다. 저자는 여기에 제주의 자원식물을 활용하여 화장품 원료등재, 건강기능식품개별인증 소재 및 천연의약품 소재 등 산업소재화 연구를 수행했었던 생물종다양성연구소의 연구 결과를 소개함으로써 유사한 목적으로 연구를 수행하는 대학, 연구소 및 기업으로의 정보를 제공하여 제주의 자원식물을 활용한 산업소재화 분야에 작은 도움이나마 제공하고자 한다.

• KSBB Journal
• /
• 제18권5호
• /
• pp.429-433
• /
• 2003

LAL 측정용 chip을 제작하기 위해서 우선 시료의 부피 감소에 대한 비탁법과 비색법을 비교하였다. 비색법은 낮은 부피에서 높은 감도를 보여 주었으며 시료의 부피와 무관하게 같은 endotoxin의 농도에서는 같은 흡광도를 보인다는 결론을 얻었다. Endotoxin의 농도에 따른 표준곡선을 end point법과 kinetic point법을 비교한 결과 대한약전의 기준에 적합한 kinetic point법이 적합하였다. 이러한 기초 실험결과를 통해 PDMS LOC를 제작하여 LAL 시험을 수행하였다. LOC를 이용하여 더 짧은 시간과 더 작은 시료로 시험이 가능하도록 하였다. 특히 PDMS LOC는 복잡한 channel을 쉽게 만들 수 있을 뿐 아니라 mold를 이용하여 상용화를 위한 대량 생산이 가능하다. 따라서 PDMS를 이용한 LOC의 제작과 실험을 통해 기존의 수작업의 LAL 시험을 LOC를 이용한 다중시료 측정과 자동화의 가능성을 제시하였다.

• 생태와환경
• /
• 제41권1호
• /
• pp.66-72
• /
• 2008

대도시의 기본 생활수준 향상을 위해 건립된 인공호는 지역적 환경요인에 의한 퇴적물 중금속 오염이 우려된다. 본 연구의 퇴적물 조사대상인 도심의 소형인공호들은 저수용량이 적고, 체류시간이 길며, 도시대기오염으로 인한 침적물낙하와 함께 호수에 유입될 수 있는 중금속이 최종적으로 퇴적물에 축적된다. 본 연구에서는 도시지역에 조성된 인공호를 대상으로 퇴적물매체에 축적된 총중금속, 용존중금속, 그리고 생물이용성 중금속의 상호연관성을 규명하고자 시도하였다. 생물이용량은 약전해질추출법(Weak-Electrolyte Extraction, WEE)에 의해 측정하였다. 도심인공호 전체 조사지역에 대한 퇴적물의 총중금속 검출빈도는 아연, 구리, 크롬, 니켈, 비소, 카드뮴 순으로 확인되었고, 총량에 대한 검출은 아연이 가장 높은 수치를 나타내었다. 총중금속에 대한 생물이용성 중금속의 비율은 중금속별, 측정지역별로 매우 상이하였으며 전반적으로 중금속의 생물이용성은 구리 (Cu)가 높은 것으로 나타났다. 높은 생물이용성을 나타낸 구리의 경우 기존독성연구 결과와 비교한 결과 높은 생태독성을 나타내고 있어 본 연구에서 예측한 현상을 지지하고 있으나, 차후 생물검정법(Bioassay)을 통한 검증이 필요할 것으로 사료된다.

• 대한본초학회지
• /
• 제28권3호
• /
• pp.61-68
• /
• 2013

Objectives : A precise and simple system of nomenclature was required to avoid error, ambiguity or confusion. Although medicinal plants must be produced or distributed based on a pharmacopoeia described origin including scientific name, the Korean Pharmacopoeia tenth edition (KP 10) had many names against the nomenclature. Therefore, this study aimed at searching correct scientific names for 241 plants in KP 10. Methods : Authoritative databases - The Plant List, International Plant Name Index, YList, Tropicos, eFloras, World Checklist of Selected Plant Families, The Global Compositae Checklist, The International Legume Database and Information Service, et al. - and previously performed researches, floras were cross-checked. Results : The arrangement of this list was designed for four cases, errors including illegitimate, nomenclatural synonyms, recommended names and decision reserved names. Consideration about the scientific names produced nine correct names for ten misspellings and illegitimate, and thirty-six correct names for forty-one nomenclatural synonyms. These results should be reflected in the next of KP 10. Separately, ten recommended names were also suggested for taxonomic synonyms which had been used indiscriminately due to diverse taxonomic opinions. In addition to those, decision reserved names were suggested for thirteen species which had been corridor of uncertainty. Then again, there was need to study about authorship, because KP 10 did not keep recommendations for author citations. Conclusions : Correction of scientific names for some medicinal plants which violated the International Code of Nomenclature would be useful to improve the accuracy of a Pharmacopoeia as the criterional materials.

• 대한본초학회지
• /
• 제28권5호
• /
• pp.29-31
• /
• 2013

Objectives : 'Reconsideration about Nomenclature of Herbs Listed in the Korean Pharmacopoeia' was published by Doh and Lee with absolute misconception of nomenclature. A critical review of Doh and Lee's paper is given, to correct the confused the concept of nomenclature and to provide proper scientific name for taxa which are discussed. Methods : This paper discusses the proper usage, as mandated by the International Code of Nomenclature. Adherence to the rules described in this paper should reduce the present confusion in the nomenclature of scientific names listed in the Korean Pharmacopoeia. Results : Although Doh and Lee proposed four categories to correct the scientific names of the Korean Pharmacopoeia using available botanical databases, they failed to show how nomenclatural concepts are applicable due to misconception of legitimacy and the confusion about synonym. From a nomenclatural perspective, 'accepted name' or 'recommended name' is a subjective term which used to be employed for convenience in a certain databases or working group without nomenclatural meaning. Doh and Lee also pointed out the standardization of author citation. However, they missed the importance of author citation error such as basionym or validating authors. Conclusions : Doh and Lee were not able to solve nomenclatural problems of the Korea Pharmacopoeia due to lack of clarity on the nomenclature code. We strongly recommend that KFDA has to commence extensive nomenclatural review for the next revision of Korea Pharmacopoeia.

• 대한본초학회지
• /
• 제30권5호
• /
• pp.75-83
• /
• 2015

Objectives : The aim of this study was to find how Northeast Asia(Korea, China, Taiwan, Japan) supervise herbal formulas in their pharmacopoeia.Methods : We compared items, formula's effects, formulations, etc and analyzed common formulas among Northeast Asia`s herbal pharmacopoeia (Korea(2010), China(2010), Taiwan(2013), Japan(16th Edition), drugs in Japan OTC Drugs (2007-2008))Results : The Korean Pharmacopoeia, the Korean Herbal Pharmacopoeia, Taiwan herbal pharmacopoeia, the japanese pharmacopoeia, drugs in Japan OTC drugs and pharmacopoeia of the People's Republic of China have 5, 251, 200, 20, 294, 1059 formulas, respectively. In comparison of pharmacopoeia`s test item, Korea and Japan has many similarity, for example, not refer to the effect of formulas. Korea and China have many inspection test of formulations in pharmacopoeia. Each country has differences in ratio of efficacy categories. For example, China especially has a higher ratio of formulas that regulate the blood and Korea has higher ratio of formulas that calm the spirit and open the sensory orifices than those of other 3 countries. There are 17 common formulas among the 4 countries and 43 common formulas among Korea, Taiwan and Japan. Comparing dosage forms, Korea, Japan, Drugs In Japan OTC drugs, Taiwan, China uses 4, 2, 14, 3, 21 formulations, respectively.Conclusions : China has many formulations and new formulas. Taiwan and Japan supervised formulas only selected by the authorities. However, Korean pharmacopoeia has similar form with Japan and need to add more formulas on demand and new formulations.

• 한국한의학연구원논문집
• /
• 제11권2호
• /
• pp.155-165
• /
• 2005

This study was investigated to determine the quality control of Oriental medicine from stores dealing in Oriental medicine around Seoul and Daegu. We tested total 120 samples that widely used 15 species in herbal medicine (Lycii Fructus, Platycodi Radix, Angelicae Gigantis Radix and 12 others) being collected from Oriental medicine clinic, pharmacy, Oriental pharmacy, Oriental medical hospital and Oriental drug store. We have estimated Oriental medicine by K.P. (Korean Pharmacopoeia), K.H.P(Korean Herbal Pharmacopoeia) and announcement of KFDA. The items of examination were identification, purity, loss on drying, ash, acid insoluble ash, extract content, essential oil content, assay, heavy metal limit, and pesticides residue(BHC, DDT, Aldrin, Endrin, Dieldrin). As a result, 20 samples in total 120 samples were not satisfied with the standard and 7 species in total 15 species were not satisfied with the standard. Identification test, extract content test and pesticides residue(BHC, DDT, Aldrin, Endrin, Dieldrin) were satisfied with the standard. The result will be the basic data for the quality control of Oriental medicine.

• 대한본초학회지
• /
• 제31권5호
• /
• pp.55-62
• /
• 2016

Objective : TM-MC was constructed to provide information on the chemical compounds of medicinal plant materials which were listed in Korean, Chinese, and Japanese pharmacopoeias. The aim of this study was to compare of the chemical compounds of TM-MC with those of domestic pharmacopoeias.Methods : First of all, TM-MC was updated on medicinal materials and chemical compounds which were extracted from articles up to the PubMed identifier of 26 millions. After searching for medicinal plant materials with information on their major compounds in Korean pharmacopoeias, we identified that the information on medicinal materials and chemical compounds were also existed in TM-MC. Then, we figured out how much the compounds have been studied by counting the number of articles for those compounds in TM-MC.Results : Information on 9 medicinal materials and about 1,700 compounds was newly added to TM-MC after manually curating 645 articles. Korean pharmacopoeias contained a total of 91compounds from 53 medicinal plant materials, while TM-MC provided information on the 89 compounds from the 53 medicinal materials in Korean pharmacopoeias. The compounds stated in Korean pharmacopoeias has been much studied by comparison with other compounds of each medicinal material in TM-MC.Conclusion : Most of chemical compounds stated in Korean pharmacopoeias were also listed in TM-MC, excluding two compounds. Thus, we concluded that information in TM-MC is mostly consistent with that of Korean pharmacopoeias. In the future, we will periodically update TM-MC with articles added to the MEDLINE.

• 대한본초학회지
• /
• 제35권5호
• /
• pp.13-21
• /
• 2020

Objective : The genus Glycyrrhiza has been used in food and traditional herbal medicine. Many experimental studies reported that Glycyrrhiza species possess several pharmacological properties. Glycyrrhiza new varieties WONGAM and SINWONGAM have been developed by Korea Rural Development Administration doing research for registration on Ministry of Food and Drug Safety. During the evaluations about pharmacological effect of Glycyrrhiza new varieties WONGAM and SINWONGAM, we focused the anti-allergic effect in this study. Methods : We investigated the anti-allergic effect of WONGAM and SINWONGAM compared with Glycyrrhiza uralensis Fischer and G. glabra L. using anti-dinitrophenyl-immunoglobulin E (IgE)/human serum albumin-stimulated RBL-2H3 cells, phorbol 12-myristate 13-acetate plus calcium ionophore A23187-stimulated HMC-1 cells and compound 48/80-induced anaphylaxis mice model. We analyzed the effect on the expression of various cytokines, and IgE from mast cells and the underlying molecular mechanisms of WONGAM and SINWONGAM in presented models. Results : WONGAM and SINWONGAM showed the inhibitory effect on the histamine release from rat peritoneal mast cells or human mast cells without cytotoxicity. WONGAM and SINWONGAM blocked anaphylactic shock and decreased the IgE production. Furthermore, WONGAM and SINWONGAM inhibited the productions of TNF-α and IL-6 in compound 48/80-induced anaphylaxis mice model. Conclusion : These results indicated that WONGAM and SINWONGAM would have protect effect on allergic responses through the inhibition of allergic mediators and pro-inflammatory cytokines. This study may facilitate the development on Glycyrrhiza new varieties for allergy.

• Journal of Pharmaceutical Investigation
• /
• 제34권5호
• /
• pp.427-433
• /
• 2004

With the Sunshine policy, exchange of materials and cultures inter Koreas has been broadened and expectancy of reunification is getting higher. Especially, medical supplies and medicines are one of the biggest parts in the exchange goods. So, preparing an unified official drug standard preparing new medical administration system is required. We compared the Korean pharmacopoeia with North Korean Pharmacopoeia. Two pharmacopoeias have been developed in different direction and have many differences in the nomenclature and format. In this study, we compared general notices, general rules for preparations and crude drugs, monographs, general tests, processes and apparatus.